Fig. 5. Effects of various treatments on albumin levels in DM and dyslipidemia rat models. *Data are presented as means ± SD of four repetitions. The different superscript marks a, b, c, d for albumin content (g/l) and a, b, bc, d for albumin content (g/mg prot) showed significant differences among treatments (p < 0.05). Group I: negative control (aquadest), Group II: positive control (HFD, PTU, STZ 60 mg/kg BW, NA 120 mg/kg BW), Group III: positive control + BPE 200 mg/kg BW/day, Group IV: positive control + BPE 400 mg/kg BW/day, Group V: positive control + BPE 800 mg/kg BW/day, Group VI: positive control + Simvastatin 0.9 mg/kg BW, Group VII: positive control + Glibenclamide 0.45 mg/kg BW, Group VIII: positive control + Glibenclamide 0.45 mg/kg BW + Simvastatin 0.9 mg/kg BW.
